SCHEMBL4897789

SCHEMBL4897789

C[C@H](Nc1c(Nc2ccc3ncsc3c2)c(=O)c1=O)c1cccc(O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 17/20 0.61
PFKFB3 Q16875 1/20 0.55
PLK1 P53350 2/20 0.47
MAPK14 Q16539 1/20 0.45
AURKB Q96GD4 4/20 0.44
ROCK1 Q13464 3/20 0.44
PDGFRA P16234 3/20 0.44
CSNK1G1 Q9HCP0 3/20 0.44
CYP2C9 P11712 2/20 0.44
MAPK1 P28482 2/20 0.44
RPS6KA1 Q15418 2/20 0.44
DCLK1 O15075 1/20 0.44
ROCK2 O75116 1/20 0.44
CHEK2 O96017 1/20 0.44
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44
IRAK1 P51617 1/20 0.44
PRKX P51817 1/20 0.44
NEK4 P51957 1/20 0.44
CSNK1G2 P78368 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905846 1.00 MAPKAPK2 (0.61) MAPKAPK2PFKFB3PLK1MAPK14AURKB
SCHEMBL4597033 0.79 KDR (0.52) MAPKAPK2PLK1AURKBROCK1PDGFRA
SCHEMBL4596962 0.77 MAPKAPK2 (0.61) MAPKAPK2PLK1MAPK14AURKBROCK1
SCHEMBL4598811 0.77 MAPKAPK2 (0.61) MAPKAPK2PLK1MAPK14AURKBROCK1
SCHEMBL4914345 0.77 MAPKAPK2 (0.67) MAPKAPK2PLK1MAPK14AURKBROCK1
SCHEMBL1228998 0.77 MAPKAPK2 (0.67) MAPKAPK2PLK1MAPK14AURKBROCK1
SCHEMBL4911215 0.77 MAPKAPK2 (0.67) MAPKAPK2PLK1MAPK14AURKBROCK1
SCHEMBL4366319 0.76 MAPKAPK2 (1.00) MAPKAPK2PLK1AURKBROCK1PDGFRA
SCHEMBL4915136 0.76 MAPKAPK2 (0.65) MAPKAPK2PLK1MAPK14AURKBROCK1
SCHEMBL4598348 0.76 MAPKAPK2 (0.65) MAPKAPK2PLK1MAPK14AURKBROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US claimed
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 MAPKAPK2 346/4885PFKFB3 53/4885PLK1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.